ReviewAdvances in biochemical engineering/biotechnology2026
Quantitative Perspectives of Biomolecular Crystallization Thermodynamics.
Review in Advances in biochemical engineering/biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advances in Downstream Processing of Monoclonal Antibodies.Antibodies (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The driving force for solution crystallization is the supersaturation, the concentration of the crystallizing species in solution over the concentration when the solution is at equilibrium with the solid phase. It is observed that macromolecule crystals typically nucleate and grow at higher supersaturations than found for small molecules. The equilibrium concentration at a defined set of conditions is a fixed point in the phase diagram and as such can be thermodynamically evaluated. The problems of working with biomolecules, such as their usually limited supply, structural flexibility, and limited stability in solution, exacerbate the problems of obtaining solubility data. This chapter, presented in four sections, focuses on proteins. Section 1 is a general review of protein crystallization and the importance of solubility in crystallization studies. Section 2 is a review of the methods that have been developed for determining protein solubility. These can be broadly differentiated into solution-based and optical approaches. As a general rule, the optimal methods for determining solubility are those that approach it from both directions, from over- and undersaturated conditions. Section 3 covers solubility data analysis and the parameters that are derived from this analysis. Section 4 reviews another commonly derived parameter, the second virial coefficient, B
Indexed as
Identifiers
41792306What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.